Terms: = Prostate cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Prognosis
139 results:
1. Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis.
Hemminki K; Zitricky F; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki O
Cancer Med; 2024 Apr; 13(7):e7126. PubMed ID: 38545829
[TBL] [Abstract] [Full Text] [Related]
2. Risk of Biochemical Recurrence in Patients With Grade Group 1 prostate cancer With Extraprostatic Extension Treated With Radical prostatectomy.
Rezaee ME; Pallauf M; Fletcher SA; Han M; Pavlovich CP; Cornelia Ding CK; Epstein JI; Allaf ME; Trock BJ; Singla N
J Urol; 2024 Mar; 211(3):407-414. PubMed ID: 38109699
[TBL] [Abstract] [Full Text] [Related]
3. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
[TBL] [Abstract] [Full Text] [Related]
4. Family structure and living arrangements as indicators of social isolation, and prostate cancer risk.
Salmon C; Quesnel-Vallée A; Parent MÉ
Prev Med; 2023 Jul; 172():107544. PubMed ID: 37178831
[TBL] [Abstract] [Full Text] [Related]
5. Association between rapid renal function deterioration and cancer mortality in the elderly: A retrospective cohort study.
Kuo IC; Chu YC; Chen YH; Chan TC
Cancer Med; 2023 Apr; 12(8):10008-10019. PubMed ID: 36880220
[TBL] [Abstract] [Full Text] [Related]
6. Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer.
Chin CP; Smith WH; Cesaretti J; Terk M; Garden EB; Araya JS; Palese MA; Stock RG; Buckstein M
Urol Oncol; 2023 Jun; 41(6):296.e9-296.e16. PubMed ID: 36588020
[TBL] [Abstract] [Full Text] [Related]
7. Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer.
Bakker A; Slack JC; Palanisamy N; Carskadon S; Ghosh S; Khalifeh I; Bismar TA
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3721-3728. PubMed ID: 35982181
[TBL] [Abstract] [Full Text] [Related]
8. Survival of cancer survivors with a new pancreatic cancer diagnosis.
Pruitt SL; Tavakkoli A; Zhu H; Heitjan DF; Gerber DE; Singal AG; Halm EA; Beg MS; Maddineni B; Kansagra AJ; Murphy CC
Cancer Med; 2023 Jan; 12(1):200-212. PubMed ID: 35674139
[TBL] [Abstract] [Full Text] [Related]
9. Development and Validation of an Artificial Intelligence-Powered Platform for prostate cancer Grading and Quantification.
Huang W; Randhawa R; Jain P; Iczkowski KA; Hu R; Hubbard S; Eickhoff J; Basu H; Roy R
JAMA Netw Open; 2021 Nov; 4(11):e2132554. PubMed ID: 34730818
[TBL] [Abstract] [Full Text] [Related]
10. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.
Pruitt SL; Gerber DE; Zhu H; Heitjan DF; Maddineni B; Xiong D; Singal AG; Tavakkoli A; Halm EA; Murphy CC
Cancer Med; 2021 Jul; 10(14):4752-4767. PubMed ID: 34190429
[TBL] [Abstract] [Full Text] [Related]
11. Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate.
Kato M; Hirakawa A; Sato H; Hanazawa R; Naito Y; Tochigi K; Sano T; Ishida S; Funahashi Y; Fujita T; Matsukawa Y; Hattori R; Tsuzuki T
Int J Clin Oncol; 2021 Apr; 26(4):764-769. PubMed ID: 33385274
[TBL] [Abstract] [Full Text] [Related]
12. [CLINICAL STUDY OF OPEN RADICAL CYSTECTOMY AND ILEAL CONDUIT CONSTRUCTION FOR BLADDER cancer: RESULTS OF 15-YEAR SINGLE CENTER EXPERIENCE].
Uemura T; Ishibashi T; Pae S; Shirakawa N; Somoto T; Shinohara M; Kobayashi M; Komaru A; Fukasawa S
Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):89-95. PubMed ID: 35444087
[TBL] [Abstract] [Full Text] [Related]
13. [Neuroendocrine differentiated prostate adenocarcinoma: Report of 23 cases and review of the literature].
Deng L; Long Z; He LY; Tang J; Liu JY; Liu B; Yao K; Zhang YC
Zhonghua Nan Ke Xue; 2020 Jan; 26(1):42-47. PubMed ID: 33345476
[TBL] [Abstract] [Full Text] [Related]
14. Robotic radical prostatectomy: analysis of midterm pathologic and oncologic outcomes: A historical series from a high-volume center.
Asimakopoulos AD; Annino F; Mugnier C; Lopez L; Hoepffner JL; Gaston R; Piechaud T
Surg Endosc; 2021 Dec; 35(12):6731-6745. PubMed ID: 33289056
[TBL] [Abstract] [Full Text] [Related]
15. Expression of Ganglioside Disialosyl Globopentaosyl Ceramide in prostate Biopsy Specimens as a Predictive Marker for Recurrence after Radical prostatectomy.
Sato M; Shimada S; Watanabe M; Kawasaki Y; Sato T; Morozumi K; Mitsuzuka K; Ito A
Tohoku J Exp Med; 2020 Sep; 252(1):1-8. PubMed ID: 32814720
[TBL] [Abstract] [Full Text] [Related]
16. Sources of selection and information biases when using commercial database-derived residential histories for cancer research.
Freeman VL; Boylan EE; Tilahun NY; Basu S; Kwan MP
Ann Epidemiol; 2020 Nov; 51():35-40.e1. PubMed ID: 32711052
[TBL] [Abstract] [Full Text] [Related]
17. Active surveillance in prostate cancer is possible for Afro-Caribbean population: Comparison of oncological outcomes with a Caucasian cohort.
Percot M; Robert G; Bladou F; Ferrière JM; Bensadoun H; Bernhard JC; Alezra E; Capon G; Sénéchal C; Gourtaud G; Brureau L; Roux V; Blanchet P; Eyraud R
Prog Urol; 2020 Sep; 30(10):532-540. PubMed ID: 32593527
[TBL] [Abstract] [Full Text] [Related]
18. Coronary artery bypass grafting in patients with concomitant solid tumours: early and long-term results.
Garatti A; D'Ovidio M; Saitto G; Daprati A; Canziani A; Mossuto E; D'Oria V; Scarpanti M; De Vincentiis C; Parolari A; Menicanti L
Eur J Cardiothorac Surg; 2020 Sep; 58(3):528-536. PubMed ID: 32474575
[TBL] [Abstract] [Full Text] [Related]
19. The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy.
Bargão Santos P; Lobo J; Félix A; Silva F; Manso RT; Costa JO; Lourenço B; Sequeira JP; Jerónimo C; Patel HHR; Henrique R
Urol Oncol; 2020 Oct; 38(10):794.e17-794.e27. PubMed ID: 32278731
[TBL] [Abstract] [Full Text] [Related]
20. Does Gleason score of positive surgical margin after radical prostatectomy affect biochemical recurrence and oncological outcomes? Protocol for systematic review.
John A; O'Callaghan M; Catterwell R; Selth L
BMJ Open; 2020 Mar; 10(3):e034612. PubMed ID: 32209629
[TBL] [Abstract] [Full Text] [Related]
[Next]
